Advice
following an abbreviated submission:
progesterone (Lubion®) is accepted for use within NHSScotland.
Indication under review: in adults for luteal support as part of an Assisted Reproductive Technology (ART) treatment program in infertile women who are unable to use or tolerate vaginal preparations.
This increases the range of progesterone preparations available for use in NHSScotland. Lubion® is an aqueous formulation and may be administered subcutaneously or intramuscularly.
Download detailed advice45KB (PDF)
Medicine details
- Medicine name:
- progesterone (Lubion)
- SMC ID:
- SMC2017
- Indication:
Indicated in adults for luteal support as part of an Assisted Reproductive Technology (ART) treatment program in infertile women who are unable to use or tolerate vaginal preparations.
- Pharmaceutical company
- Pharmasure Ltd
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 09 July 2018